Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

  1. Peeters, M.
  2. Oliner, K.S.
  3. Price, T.J.
  4. Cervantes, A.
  5. Sobrero, A.F.
  6. Ducreux, M.
  7. Hotko, Y.
  8. André, T.
  9. Chan, E.
  10. Lordick, F.
  11. Punt, C.J.A.
  12. Strickland, A.H.
  13. Wilson, G.
  14. Ciuleanu, T.E.
  15. Roman, L.
  16. Van Cutsem, E.
  17. He, P.
  18. Yu, H.
  19. Koukakis, R.
  20. Terwey, J.-H.
  21. Jung, A.S.
  22. Sidhu, R.
  23. Patterson, S.D.
Revue:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Année de publication: 2015

Volumen: 21

Número: 24

Pages: 5469-5479

Type: Article

DOI: 10.1158/1078-0432.CCR-15-0526 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus